Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitrates in myocardial infarction

B I Jugdutt1

  • 1Department of Medicine, University of Alberta, Edmonton, Canada.

Cardiovascular Drugs and Therapy
|August 1, 1994
PubMed
Summary

Low-dose intravenous nitroglycerin (i.v. NTG) is safe and effective in limiting infarct size and improving outcomes after acute myocardial infarction (MI). However, prolonged nitrate therapy does not significantly improve long-term survival in MI patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiotensin II antagonism. Cardioprotection and angiotensin receptor blockade.

IDrugs : the investigational drugs journal·2005
Same author

Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

British journal of pharmacology·2001
Same author

Effect of chronic AT(1) receptor antagonism on postischemic functional recovery and AT(1)/AT(2) receptor proteins in isolated working rat hearts.

Journal of cardiovascular pharmacology and therapeutics·2001
Same author

Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts.

Journal of hypertension·2001

Area of Science:

  • Cardiology
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Nitroglycerin was historically contraindicated in acute myocardial infarction (MI).
  • Canine models showed low-dose intravenous (i.v.) nitroglycerin reduced left ventricular (LV) preload, improved perfusion, and limited infarct size in early MI.
  • Higher doses led to a paradoxical J-curve effect, increasing infarct size due to hypoperfusion.

Purpose of the Study:

  • To evaluate the safety and efficacy of low-dose i.v. nitroglycerin in acute myocardial infarction.
  • To assess the impact of nitroglycerin on left ventricular function, infarct size, and remodeling.
  • To determine the benefits of prolonged nitrate therapy in the healing phase of MI.

Main Methods:

  • Clinical studies involving low-dose i.v. nitroglycerin infusion within the first 48 hours post-MI.
  • Analysis of infarct size, left ventricular remodeling, and clinical outcomes (in-hospital and up to 1 year).
  • Review of preliminary results from the ISIS-4 megatrial on long-term nitrate therapy.

Main Results:

  • Low-dose i.v. nitroglycerin is safe and improves LV performance in heart failure post-MI.
  • This therapy limits ischemic injury, infarct size, remodeling, and associated complications, including mortality.
  • Prolonged nitrate therapy during the healing phase may further limit LV remodeling and preserve function.
  • The ISIS-4 trial indicated long-term nitrate use does not significantly improve survival in suspected MI patients.

Conclusions:

  • Early, low-dose i.v. nitroglycerin is a beneficial treatment for acute myocardial infarction, improving cardiac function and reducing infarct size.
  • While short-term use is advantageous, long-term nitrate therapy does not offer significant survival benefits in the broader MI population.
  • Further research may explore optimal duration and patient selection for nitrate therapy in specific MI contexts.

Related Experiment Videos